Trial Profile
Absolute Quantification of Coronary Flow Reserve by Stress Perfusion MRI
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Regadenoson (Primary) ; Gadofosveset
- Indications Myocardial ischaemia
- Focus Diagnostic use
- 23 Apr 2015 New trial record
- 26 Mar 2015 Status change from not yet recruiting to completed, as per ClinicalTrials.gov record.